There are 2949 resources available
Self-management and patient education
Presenter: Manuela Eicher
Session: EONS13: Opening session
Resources:
Slides
Webcast
Award session and live discussion, all Speakers online Chairs to moderate Q&A
Presenter: Andreas Charalambous
Session: EONS13: Opening session
Resources:
Webcast
910O - Primary results of the phase III JAVELIN head & neck 100 trial: Avelumab plus chemoradiotherapy (CRT) followed by avelumab maintenance vs CRT in patients with locally advanced squamous cell carcinoma of the head and neck (LA SCCHN)
Presenter: Ezra Cohen
Session: Proffered Paper - Head & Neck cancer
Resources:
Abstract
Slides
Webcast
LBA39 - 3-years follow-up of double-blind randomized phase II comparing concurrent high-dose cisplatin chemo-radiation plus xevinapant or placebo in high-risk patients with locally advanced squamous cell carcinoma of the head and neck
Presenter: Jean Bourhis
Session: Proffered Paper - Head & Neck cancer
Resources:
Abstract
Slides
Webcast
LBA40 - Neoadjuvant nivolumab and nivolumab plus ipilimumab induce (near-) complete responses in patients with head and neck squamous cell carcinoma: The IMCISION trial
Presenter: Lotje Zuur
Session: Proffered Paper - Head & Neck cancer
Resources:
Abstract
Slides
Webcast
911O - Performance of dual p16 and HPV testing for determining prognosis in cancer of the oropharynx, the EPIC-OPC Study
Presenter: Miren Taberna
Session: Proffered Paper - Head & Neck cancer
Resources:
Abstract
Slides
Webcast
1214O - Neoadjuvant durvalumab in resectable non-small cell lung cancer (NSCLC): Preliminary results from a multicenter study (IFCT-1601 IONESCO)
Presenter: Marie Wislez
Session: Proffered Paper - Non-metastatic NSCLC and other thoracic malignancies
Resources:
Abstract
Slides
Webcast
1215O - Neoadjuvant atezolizumab (A) for resectable non-small cell lung cancer (NSCLC): results from the phase II PRINCEPS trial.
Presenter: Benjamin Besse
Session: Proffered Paper - Non-metastatic NSCLC and other thoracic malignancies
Resources:
Abstract
Slides
Webcast
LBA84 - Consolidation ipilimumab and nivolumab vs observation in limited stage SCLC after chemo-radiotherapy: Results from the ETOP/IFCT 4-12 STIMULI trial
Presenter: Solange Peters
Session: Proffered Paper - Non-metastatic NSCLC and other thoracic malignancies
Resources:
Abstract
Slides
Webcast
1783O - Patient reported outcomes from a randomized phase II trial comparing standard-dose with high-dose twice daily (BID) thoracic radiotherapy (TRT) in limited stage small cell lung cancer (LS SCLC)
Presenter: Bjorn Gronberg
Session: Proffered Paper - Non-metastatic NSCLC and other thoracic malignancies
Resources:
Abstract
Slides
Webcast